Strides Pharma Science Limited (NSE:STAR)
India · Delayed Price · Currency is INR 1,155.20
-1.70 (-0.15%)
May 11, 2026, 3:30 PM IST
Strides Pharma Science Market Cap
Strides Pharma Science has a market cap or net worth of 106.63 billion as of May 11, 2026. Its market cap has increased by 77.19% in one year.
Market Cap
106.63B
Enterprise Value
123.27B
Revenue
47.26B
Ranking
n/a
PE Ratio
20.85
Stock Price
1,155.20
Market Cap Chart
Since February 2, 2000, Strides Pharma Science's market cap has increased from 7.49B to 106.63B, an increase of 1,322.94%. That is a compound annual growth rate of 10.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 106.63B | 28.49% |
| Dec 31, 2025 | 82.99B | 36.56% |
| Dec 31, 2024 | 60.77B | 1.87% |
| Dec 29, 2023 | 59.66B | 88.83% |
| Dec 30, 2022 | 31.59B | -21.29% |
| Dec 31, 2021 | 40.14B | -49.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Piramal Pharma | 238.81B |
| NATCO Pharma | 210.40B |
| Eris Lifesciences | 192.03B |
| Cohance Lifesciences | 186.77B |
| Alembic Pharmaceuticals | 152.64B |
| Alivus Life Sciences | 137.62B |
| Akums Drugs and Pharmaceuticals | 85.29B |
| Sudeep Pharma | 74.32B |